Cargando…

WCN23-0190 HIGH SEROCONVERSION RATES AFTER 2 DOSES OF VACCINE AGAINST SARS-COV-2 IN KIDNEY TRANSPLANT RECIPIENTS

Detalles Bibliográficos
Autores principales: Bajpai, D., bose, S., kumar, K., rao, N., thakare, S., saxena, N., nataraj, G., jamale, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025596/
http://dx.doi.org/10.1016/j.ekir.2023.02.1026
_version_ 1784909369076350976
author Bajpai, D.
bose, S.
kumar, K.
rao, N.
thakare, S.
saxena, N.
nataraj, G.
jamale, T.
author_facet Bajpai, D.
bose, S.
kumar, K.
rao, N.
thakare, S.
saxena, N.
nataraj, G.
jamale, T.
author_sort Bajpai, D.
collection PubMed
description
format Online
Article
Text
id pubmed-10025596
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-100255962023-03-21 WCN23-0190 HIGH SEROCONVERSION RATES AFTER 2 DOSES OF VACCINE AGAINST SARS-COV-2 IN KIDNEY TRANSPLANT RECIPIENTS Bajpai, D. bose, S. kumar, K. rao, N. thakare, S. saxena, N. nataraj, G. jamale, T. Kidney Int Rep Covid-19 and KF (Kidney Failure) Published by Elsevier Inc. 2023-03 2023-03-20 /pmc/articles/PMC10025596/ http://dx.doi.org/10.1016/j.ekir.2023.02.1026 Text en Copyright © 2023 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Covid-19 and KF (Kidney Failure)
Bajpai, D.
bose, S.
kumar, K.
rao, N.
thakare, S.
saxena, N.
nataraj, G.
jamale, T.
WCN23-0190 HIGH SEROCONVERSION RATES AFTER 2 DOSES OF VACCINE AGAINST SARS-COV-2 IN KIDNEY TRANSPLANT RECIPIENTS
title WCN23-0190 HIGH SEROCONVERSION RATES AFTER 2 DOSES OF VACCINE AGAINST SARS-COV-2 IN KIDNEY TRANSPLANT RECIPIENTS
title_full WCN23-0190 HIGH SEROCONVERSION RATES AFTER 2 DOSES OF VACCINE AGAINST SARS-COV-2 IN KIDNEY TRANSPLANT RECIPIENTS
title_fullStr WCN23-0190 HIGH SEROCONVERSION RATES AFTER 2 DOSES OF VACCINE AGAINST SARS-COV-2 IN KIDNEY TRANSPLANT RECIPIENTS
title_full_unstemmed WCN23-0190 HIGH SEROCONVERSION RATES AFTER 2 DOSES OF VACCINE AGAINST SARS-COV-2 IN KIDNEY TRANSPLANT RECIPIENTS
title_short WCN23-0190 HIGH SEROCONVERSION RATES AFTER 2 DOSES OF VACCINE AGAINST SARS-COV-2 IN KIDNEY TRANSPLANT RECIPIENTS
title_sort wcn23-0190 high seroconversion rates after 2 doses of vaccine against sars-cov-2 in kidney transplant recipients
topic Covid-19 and KF (Kidney Failure)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025596/
http://dx.doi.org/10.1016/j.ekir.2023.02.1026
work_keys_str_mv AT bajpaid wcn230190highseroconversionratesafter2dosesofvaccineagainstsarscov2inkidneytransplantrecipients
AT boses wcn230190highseroconversionratesafter2dosesofvaccineagainstsarscov2inkidneytransplantrecipients
AT kumark wcn230190highseroconversionratesafter2dosesofvaccineagainstsarscov2inkidneytransplantrecipients
AT raon wcn230190highseroconversionratesafter2dosesofvaccineagainstsarscov2inkidneytransplantrecipients
AT thakares wcn230190highseroconversionratesafter2dosesofvaccineagainstsarscov2inkidneytransplantrecipients
AT saxenan wcn230190highseroconversionratesafter2dosesofvaccineagainstsarscov2inkidneytransplantrecipients
AT natarajg wcn230190highseroconversionratesafter2dosesofvaccineagainstsarscov2inkidneytransplantrecipients
AT jamalet wcn230190highseroconversionratesafter2dosesofvaccineagainstsarscov2inkidneytransplantrecipients